Anita Dushyanth
Stock Analyst at Berenberg
(2.71)
# 2,078
Out of 5,008 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $16.83 | +18.84% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $3.25 | +300.00% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $2.50 | +47,900.00% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $23.62 | +293.73% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $16.83
Upside: +18.84%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $3.25
Upside: +300.00%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $2.50
Upside: +47,900.00%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $23.62
Upside: +293.73%